Sio Capital Management’s Stemline Therapeutics STML Stock Holding History
Bought
Maintained
Sold
Other funds holding STML
Sio Capital Management's STML Position: Q2 2015 in Review
Sio Capital Management sold out of Stemline Therapeutics (STML) in Q2 2015, closing a stake of 140,000 shares — an estimated $2.03M sold.
Sio Capital Management first reported a position in STML in Q1 2015 and held it in 1 quarter. The position peaked at $2.03M in Q1 2015. 71 funds tracked by Wall St. Rank hold STML as of Q2 2015.
- Sio Capital Management reported no remaining Stemline Therapeutics position as of Q2 2015 after selling out during the quarter.
- Sio Capital Management sold 140,000 Stemline Therapeutics shares in Q2 2015, an estimated $2.03M.
- Sio Capital Management first reported a position in Stemline Therapeutics in Q1 2015 and held it in 1 quarter.
- Sio Capital Management's Stemline Therapeutics position peaked at $2.03M in Q1 2015.
- 71 funds tracked by Wall St. Rank held Stemline Therapeutics as of Q2 2015.
Based on Sio Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.